Latex Allergy - From Discovery to Component-resolved Diagnosis.

Endocr Metab Immune Disord Drug Targets

Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Policlinico di Bari, Bari, Italy.

Published: May 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Latex allergy is a hypersensitivity response to natural rubber latex (NRL) proteins or rubber chemicals used in the manufacture of latex products. An accurate diagnosis is the first step in the effective management of individuals with latex allergy, especially in high-risk groups, such as healthcare workers and those affected by spina bifida. Diagnosis is based on the clinical history and an accurate allergological evaluation. In the case of type I IgE-mediated hypersensitivity reactions, which can manifest urticaria, angioedema, rhinoconjunctivitis, asthma and anaphylaxis after latex exposure, skin prick tests or latex-specific IgE (sIgE) antibody detection using serological assays can be performed to confirm sensitization. Instead, in the case of contact dermatitis, a patch test can be applied to confirm the presence of a type IV T cell-mediated hypersensitivity reaction to rubber accelerators or additives. Basophils activation tests or challenge tests may be performed if there's an incongruity between the clinical history and the results of and tests. The aim of this review is to analyze the current state of the art of diagnostic techniques for latex allergy and algorithms employed in clinical practice and possible future developments in this field.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1871530323666230901102131DOI Listing

Publication Analysis

Top Keywords

latex allergy
16
clinical history
8
latex
7
allergy discovery
4
discovery component-resolved
4
component-resolved diagnosis
4
diagnosis latex
4
allergy hypersensitivity
4
hypersensitivity response
4
response natural
4

Similar Publications

Potential Allergens in Medical Adhesives in Tapes, Wound Dressings, and Ostomy Care: A Scoping Review.

Contact Dermatitis

August 2025

Department of Dermatology, University Hospital Antwerp (UZA), and Research Group Immunology, University of Antwerp, Antwerp, Belgium.

Background: Medical adhesives are increasingly reported, although still underestimated as causes of allergic contact dermatitis, for which identification of the sensitising culprits is often impossible, mainly because of non-declaration of components on medical device packaging and lack of cooperation from manufacturers.

Objectives: To report on the allergens identified in medical adhesives in tapes, wound dressings, and ostomy care.

Methods: The relevant literature (1980-2024) on sensitization sources and allergens was analysed and the results reported.

View Article and Find Full Text PDF

EGR2 maintains neuropathic pain by promoting microglial phagocytosis.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

April 2025

Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008.

Objectives: Neuropathic pain (NP) is one of the most common forms of chronic pain, yet current treatment options are limited in effectiveness. Peripheral nerve injury activates spinal microglia, altering their inflammatory response and phagocytic functions, which contributes to the progression of NP. Most current research on NP focuses on microglial inflammation, with relatively little attention to their phagocytic function.

View Article and Find Full Text PDF

Background: The carba mix is used to screen rubber chemical allergy and consists of three rubber sensitising chemicals: 1% (w/w) zinc diethyldithiocarbamate (ZDEC), 1% (w/w) zinc dibutyldithiocarbamate (ZDBC) and 1% (w/w) 1,3-diphenylguanidine (DPG), all in petrolatum. However, carba mix patch test results can be difficult to interpret, which may be linked to so-called 'cocktail' effects.

Objectives: The carba mix was used as a 'model mixture' to better understand human reactions observed in clinical patch testing.

View Article and Find Full Text PDF

Major systemic complications during and immediately after brachytherapy are rare. Herein, we described a case of acute myocardial infarction due to Kounis syndrome after low-dose-rate brachytherapy in a 70-year-old man with a banana allergy. Following low-dose-rate brachytherapy under general anesthesia, the patient complained of itching throughout his body; electrocardiography showed ventricular fibrillation.

View Article and Find Full Text PDF

Objective: To investigate the prophylactic effect of compression therapy against chemotherapy-induced peripheral neuropathy (CIPN) through meta-analytic evaluation.

Methods: Systematically searched PubMed, Embase, Web of Science, Cochrane Library, Scopus, and Chinese databases (CBM, CNKI, Wan fang, VIP) until December 2024. Included studies were RCTs and quasi-experimental designs.

View Article and Find Full Text PDF